Clinical Trial Update: Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating doxycycline to upgrade organ response in light chain (AL) amyloidosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Primary Systemic Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2020-01-07